<DOC>
	<DOCNO>NCT00420537</DOCNO>
	<brief_summary>The purpose study verify combination Everolimus low dose cyclosporine effective combination mycophenolate mofetil low-dose cyclosporine reduce progression kidney dysfunction patient heart transplantation .</brief_summary>
	<brief_title>Shift Everolimus ( RAD ) Kidney Sparing Study</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Heart Transplant 1 4 year followup GFR 20 60 ml/min ( calculate ColkoroftGault formula ) Acute rejection previous 6 month Contraindications statin therapy Ongoing infection Ongoing heart failure Myocardial infarction myocardial revascularization transplant Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Heart Transplantation</keyword>
	<keyword>Creatinine</keyword>
	<keyword>Glomerular Filtration Rate</keyword>
</DOC>